As part of its mandate to oversee and coordinate joint work under the EU Health Technology Assessment Regulation (HTAR), the HTA Coordination Group developed and adopted the Guiding principles on data transparency on 14 May 2026.
The purpose of the document is to provide general principles on data transparency to be used when assessing the requests for confidentiality from health technology developers in the context of EU joint clinical assessments. It also outlines how transparency considerations apply to joint scientific consultations.
During its General Meeting held in Paphos, Cyprus, on 29 May 2026, the Heads of HTA Agencies Group (HAG) highlighted the importance of transparency for European collaboration on HTA, in line with the objectives of the HTAR. The heads welcomed the guiding principles, stressing their contribution to predictability in joint work under the HTAR and their role in guiding all actors involved in the processes.
